USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Sep 30, 2021 (est) | Jun 30, 2021 | - | $-0.36 | $-0.05 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Sep 30, 2021 (est) | Jun 30, 2021 | - | $0.00 | $0.00 |
Enochian Biosciences, Inc's next estimated earnings date (based on same quarter last year's date) is Sep 30, 2021 for the fiscal quarter ending Jun 30, 2021.
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Jun 30, 2021 | Jun 2021 | - | $-0.33 | - |
| Jun 30, 2021 | Mar 2021 | - | $-0.36 | - |
| Mar 31, 2021 | Dec 2020 | - | $-0.09 | - |
| Dec 31, 2020 | Sep 2020 | - | $-0.06 | - |
| Sep 30, 2020 | Jun 2020 | - | $-0.05 | - |
| Jun 30, 2020 | Mar 2020 | - | $-0.09 | - |
| Mar 31, 2020 | Dec 2019 | - | $-0.03 | - |
| Dec 31, 2019 | Sep 2019 | - | $-0.04 | - |
| Sep 30, 2019 | Jun 2019 | - | $-0.09 | - |
| Jun 30, 2019 | Mar 2019 | - | $0.03 | - |
| Mar 31, 2019 | Dec 2018 | - | $-0.07 | - |
| Dec 31, 2018 | Sep 2018 | - | $-0.45 | - |
| Sep 30, 2018 | Jun 2018 | - | $-0.01 | - |
| Jun 30, 2018 | Mar 2018 | - | $-0.06 | - |
| Mar 31, 2018 | Dec 2017 | - | $-0.12 | - |
| Dec 31, 2017 | Sep 2017 | - | $-0.08 | - |
| Sep 30, 2017 | Jun 2017 | - | $-0.02 | - |
| Jun 30, 2017 | Mar 2017 | - | $-0.01 | - |
| Mar 31, 2017 | Dec 2016 | - | $-0.03 | - |
| Sep 30, 2016 | Sep 2016 | - | $-0.08 | - |
| Jun 30, 2016 | Jun 2016 | - | $-0.08 | - |
| Mar 31, 2016 | Mar 2016 | - | $-0.02 | - |
| Dec 31, 2015 | Dec 2015 | - | $-0.04 | - |
| Sep 30, 2015 | Sep 2015 | - | $-0.04 | - |
| Mar 31, 2015 | Mar 2015 | - | $-0.13 | - |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Jun 30, 2021 | Jun 2021 | - | $-0.84 | - |
| Sep 30, 2020 | Jun 2020 | - | $-0.21 | - |
| Sep 30, 2019 | Jun 2019 | - | $-0.58 | - |
| Sep 30, 2018 | Jun 2018 | - | $-0.26 | - |
| Sep 30, 2017 | Jun 2017 | - | $-0.14 | - |
| Jun 30, 2016 | Jun 2016 | - | $-0.31 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Jun 30, 2021 | Jun 2021 | - | $0.00 | - |
| Jun 30, 2021 | Mar 2021 | - | $0.00 | - |
| Mar 31, 2021 | Dec 2020 | - | $0.00 | - |
| Dec 31, 2020 | Sep 2020 | - | $0.00 | - |
| Sep 30, 2020 | Jun 2020 | - | $0.00 | - |
| Jun 30, 2020 | Mar 2020 | - | $0.00 | - |
| Mar 31, 2020 | Dec 2019 | - | $0.00 | - |
| Dec 31, 2019 | Sep 2019 | - | $0.00 | - |
| Sep 30, 2019 | Jun 2019 | - | $0.00 | - |
| Jun 30, 2019 | Mar 2019 | - | $0.00 | - |
| Mar 31, 2019 | Dec 2018 | - | $0.00 | - |
| Dec 31, 2018 | Sep 2018 | - | $0.00 | - |
| Sep 30, 2018 | Jun 2018 | - | $0.00 | - |
| Jun 30, 2018 | Mar 2018 | - | $0.00 | - |
| Mar 31, 2018 | Dec 2017 | - | $0.00 | - |
| Dec 31, 2017 | Sep 2017 | - | $0.00 | - |
| Sep 30, 2017 | Jun 2017 | - | $0.00 | - |
| Jun 30, 2017 | Mar 2017 | - | $0.00 | - |
| Mar 31, 2017 | Dec 2016 | - | - | - |
| Sep 30, 2016 | Sep 2016 | - | $244.00 | - |
| Jun 30, 2016 | Jun 2016 | - | $244.00 | - |
| Mar 31, 2016 | Mar 2016 | - | - | - |
| Dec 31, 2015 | Dec 2015 | - | $42.52K | - |
| Sep 30, 2015 | Sep 2015 | - | - | - |
| Mar 31, 2015 | Mar 2015 | - | - | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Jun 30, 2021 | Jun 2021 | - | $0.00 | - |
| Sep 30, 2020 | Jun 2020 | - | $0.00 | - |
| Sep 30, 2019 | Jun 2019 | - | $0.00 | - |
| Sep 30, 2018 | Jun 2018 | - | $0.00 | - |
| Sep 30, 2017 | Jun 2017 | - | $0.00 | - |
| Jun 30, 2016 | Jun 2016 | - | $42.77K | - |
ENOB's next estimated earnings date (based on same quarter last year's report date) is Sep 30, 2021 for the fiscal quarter ending Jun 30, 2021.
Enochian Biosciences, Inc's previous earnings date was Jun 30, 2021 for its fiscal quarter ended Mar 31, 2021.
ENOB's earnings per share (EPS) was $-0.36.
The EPS was lower than the previous fiscal quarter (Dec 2020) by 315.31%, and lower than the same period a year before (Mar 2020) by 305.90%.
Revenues were $0.00.
The company reported a net income of $-4.03M.Free cash flow for the quarter was $-2.33M , compared to $-2.51M last quarter and $-3.88M a year before.
ENOB ended the quarter with $7.31M in total debt, a decrease of -3.85% compared to the previous quarter, and a decrease of -3.54% compared to the same quarter a year before.
Enochian Biosciences, Inc's previous annual earnings date was Jun 30, 2021 for its fiscal year ended Jun 30, 2021.
ENOB's earnings per share (EPS) was $-0.84.
Revenues were $0.00.
The company reported a net income of $-26.72M.
Enochian Biosciences, Inc reported a free cash flow of $-20.66M for its fiscal year, compared to $-10.64M a year ago.
The company ended the fiscal year with $7.31M in total debt, an increase of 20.80% compared to the previous year.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.
